In MLL-rearranged leukaemia, increased glycolytic activity in combination with increased levels of HIF-1α leads to resistance to inhibition of mitochondrial respiration [222], whereas inhibitors against HIF-1α are currently in development and have been proven to have antitumour activity in MM [223]. The gene discussed is KMT2A; the disease is leukemia.